SELLAS Life Sciences Group Inc (NASDAQ:SLS) currently has a daily average trading volume of 1.48M but it saw 9471472 shares traded in last market. With a market cap of 72.03M USD, the company’s current market price of $1.28 came rising about 3.23 while comparing to the previous closing price of $1.24. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.91 and as low as $0.50.
Taking a look at 20-day trading activity of SELLAS Life Sciences Group Inc (SLS) gives us an average price of $1.4093, while its current price level is -33.12% below from 52-week high level whereas it is 156.72% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.2311 while that of 200 days or SMA-200 reads an average of $1.1683. A closer look into the stock’s movement over the week reveals that its volatility is standing at 13.50% during that period while stretching the period over a month that decreases to 11.14%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 46.71 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Cantor Fitzgerald which initiated the stock as “Overweight” in its note to investors issued on July 21, 2021, recommending a price target of $18 for it. H.C. Wainwright also issued its recommendations for the stock as it initiated the price target for the stock is $11.
Over the week, SLS’s stock price is moving -16.88% down while it is 8.47% when we observe its performance for the past one month. Year-to-date it is 20.75% up and over the past year, the stock is showing a downside performance of -14.09%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -0.47 beaten by the consensus estimate of -0.29 for the same.
Currently, SELLAS Life Sciences Group Inc’s total number of outstanding shares is 56.27M. Company’s return on equity (ROE) at -874.00%. Stock’s beta reads 2.26. Its return on asset (ROA) is -271.27% on average.
